Breaking News

Aprea Therapeutics, a cutting-edge biopharmaceutical company, has recently unveiled a private placement financing round expected to reach $34 million. Spearheaded...

Acelyrin has just released exciting top-line results from their global Phase 2B/3 trial of Izokibep in psoriatic arthritis, hitting the...

Gilead Sciences, Inc. has successfully completed the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 for its cash...

Piper Sandler analyst Ian Macpherson has reiterated a Neutral rating on Transocean (NYSE: RIG) on March 11, 2024. Macpherson has...

James Defranco, Director of EchoStar Corporation, made a significant investment on March 11, 2024, by purchasing 90,000 shares of EchoStar...

Bruker has unveiled groundbreaking advancements in 4D-Proteomics timsTOF technology, setting a new standard for proteomics applications. These cutting-edge capabilities were...

Monte Rosa Therapeutics has recently announced the commencement of IND enabling studies for MRT-8102, a groundbreaking NEK7-targeted molecular glue degrader...

Perion has recently announced a groundbreaking partnership with Way.io, establishing its presence in the Chinese market. This new venture signifies...

Lexicon Pharmaceuticals is gearing up to resubmit its New Drug Application (NDA) for sotagliflozin as a complement to insulin treatment...

Uranium Energy (AMEX:UEC) announced a decline in its quarterly financial performance on March 11, 2024. The company's earnings per share...